Perrigo Company PLC has voluntarily recalled multiple lots of Regular and Maximum Strength Acid Reducer, Ranitidine tablets (generic Zantac), across various store brands like CVS Health, Walgreens, Equate, and Up & Up. The recall was initiated because the products may contain an impurity called N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen. These over-the-counter medications were distributed nationwide in the United States in various tablet counts and strengths ranging from 75 mg to 150 mg.
The tablets may contain NDMA, a substance that could increase the risk of cancer with long-term exposure. While no immediate injuries or adverse events were reported in the data, the presence of this impurity is a deviation from current Good Manufacturing Practices (cGMP).
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.